Upon antigen recognition, tumor-specific CD8+ T cells have an unsurpassed capacity to eliminate tumor cells through the release of proinflammatory cytokines such as interferon (IFN)-γ and tumor necrosis factor (TNF)-α, and cytotoxic molecules including granzyme B and perforin [6]. The gene discussed is PRF1; the disease is neoplasm.